India's leading animal health company making veterinary APIs and formulations under the Alivira brand across 90+ countries.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 87 |
| Reserves | 637 | 678 | 642 | 649 | 607 | 2.4k | 759 | 2.8k |
| Borrowings | 343 | 277 | 365 | 444 | 488 | 654 | 490 | 490 |
| Other Liabilities | 424 | 381 | 378 | 374 | 389 | 1.0k | 427 | 1.2k |
| Total Liabilities | 1.5k | 1.4k | 1.4k | 1.5k | 1.5k | 4.1k | 1.7k | 4.6k |
| AssetsFixed Assets | 577 | 536 | 564 | 605 | 592 | 2.1k | 628 | 2.1k |
| CWIP | 13 | 31 | 12 | 55 | 16 | 43 | 5 | 70 |
| Investments | 171 | 83 | 38 | 0 | 4 | 0 | 0 | 0 |
| Other Assets | 693 | 737 | 821 | 856 | 922 | 2.0k | 1.1k | 2.4k |
| Total Assets | 1.5k | 1.4k | 1.4k | 1.5k | 1.5k | 4.1k | 1.7k | 4.6k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 116 | 115 | 115 | 31 | 17 | 31 | 345 | 323 |
| Cash from Investing | -68 | -72 | 10 | -94 | -65 | -6 | -448 | -84 |
| Cash from Financing | -20 | -43 | -139 | 67 | 32 | -1 | 87 | -123 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 92 | 75 | 70 | -1 | -58 | 19 | 258 | 225 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
SEQUENT · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.